Answers are grounded in this paper and cite their sources.
The objective is to provide a comprehensive overview of the rapidly developing field of the current state of research on in vivo use of hypochlorous acid (HOCl) to aid infection prevention and control, including naso-pharyngeal, alveolar, topical, and systemic HOCl applications. Also, examples are provided of dedicated applications in COVID-19. A brief background of HOCl's biological and chemical specifics and its physiological role in the innate immune system is provided to understand the effect of in vivo applications in the context of the body's own physiological defense mechanisms.
No takes yet. Share an insight, caveat, or question.
Boecker et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: